GSE202672
Effect of HAPLN1-PTR1 on RPMI8226 multiple myeloma cells
To investigate the role of HAPLN1 in multiple myeloma, we treated RPMI8226 multiple myeloma cells with recombinant HAPLN1-PTR1. We then performed gene expression profiling analysis using data obtained from RNA-seq. Overall design: Comparative gene expression profiling analysis of RNA-seq data for RPMI8226 multiple myeloma cells treated with 100 nM GST (control) or GST-PTR1 (experimental group) for 6 h.